Company Filing History:
Years Active: 2019
Title: Agnieszka Sobolewska: Innovator in Vaccine Development
Introduction
Agnieszka Sobolewska is a prominent inventor based in Warsaw, Poland. She has made significant contributions to the field of biotechnology, particularly in vaccine development. Her innovative work focuses on creating effective solutions to combat influenza viruses.
Latest Patents
Agnieszka holds a patent for the invention titled "Influenza virus hemagglutinin protein as a vaccine antigen." This invention relates to the hemagglutinin protein from the highly pathogenic avian influenza virus (HPAIV) H5N1 strain. The protein is expressed in a bacterial expression system and serves as a potential ingredient for an anti-HPAIV H5N1 vaccine. This vaccine can be administered to chickens either parenterally or through mucous membranes, often in conjunction with adjuvants. The patent also includes a method for obtaining the vaccine protein.
Career Highlights
Agnieszka is affiliated with the Institute of Biotechnology and Antibiotics, where she continues her research and development efforts. Her work is crucial in addressing public health challenges posed by influenza viruses.
Collaborations
Agnieszka collaborates with notable colleagues, including Violetta Sączyńska and Agnieszka Romanik, who contribute to her research initiatives.
Conclusion
Agnieszka Sobolewska's innovative work in vaccine development highlights her commitment to advancing biotechnology. Her contributions are vital in the ongoing fight against influenza viruses, showcasing the importance of research in public health.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.